A breakthrough zwitterionic polymer slips through the skin’s toughest barriers, carrying insulin deep into tissue and normalizing blood sugar, offering patients a painless alternative to daily injections.
A recent study published in the journal Nature examines the use of the skin-permeable molecule poly[2-(N-oxide-N,N-dimethylamino)ethyl methacrylate] (OP) as a delivery system for insulin, a key drug in the treatment of type 1 and many cases of type 2 diabetes mellitus.
Small-molecule drugs are often designed to be absorbed through the skin. However, this has not been found feasible for large biomolecules, such as proteins and peptides like insulin.
Barriers to insulin delivery
Insulin is typically administered by intradermal injection. This method is painful, can induce fear of needles, and skin complications, all of which are linked to poor patient compliance. No successful noninvasive technique of insulin delivery has yet been reported.
Transdermal drug delivery offers several advantages, including improved patient compliance, convenience, increased active drug concentration by avoiding denaturation, and reduced first-pass metabolism of the drug. Among the greatest challenges in this approach is getting past the stratum corneum (SC) of the skin.
The SC is composed of dead and dried-out corneocytes surrounded by a well-ordered fatty matrix. Along with the epithelial tight junctions in the epidermis and dermis, this presents a barrier to drug penetration. Potential approaches include chemical penetration enhancers, electrically-driven devices that force the drug to penetrate the skin, and injection by ultrasound or jet rather than hypodermic needles, as well as microneedles. Being invasive, these are, however, associated with a higher risk of infection.
Cationic peptides can sometimes pass through the skin, bound to organic acids in the sebum and stratum corneum. However, this binding immobilizes them in the SC, preventing their deeper diffusion. Their only route lies through the hair follicles and sweat glands, comprising <0.1 % of skin area, meaning penetration is inefficient.
This prompted the current exploration of the novel polymer OP. The extreme skin permeability of OP-I does not involve any change in skin lipid ordering or structure. Instead, molecular dynamics simulations revealed that OP-I was adsorbed by stratum corneum fats faster than native insulin, diffusing rapidly through the lipids to reach the dermis and subcutaneous tissue.
This was characterized by a transition from its protonated cationic state (at a pH of 5 or lower) to a zwitterion during its skin passage (at neutral pH). This pH-dependent charge shift aligns with the skin’s acidic-to-neutral gradient and is central to OP’s transport behavior.
OP can thus pass quickly and smoothly through the skin into the blood and lymph vessels. OP and OP–insulin primarily enter systemic circulation through leaky lymphatic capillaries before reaching the bloodstream.
Study findings
OP diffusion
The researchers applied fluorescent-labeled OP to the skin surface of mice and minipigs (the skin of the latter being very similar to human skin) and tracked its passage through the skin using high-resolution imaging.
In mice, OP diffused throughout all skin layers within four hours of topical application, whereas the control polyethylene glycol (PEG) remained on the skin surface. In the epidermis and dermis, OP-I moved by membrane-mediated diffusion without entering the cell. This involved rapid “hopping” along adjacent cell membranes rather than intracellular transport.
Further confirmation was obtained by visualizing the OP-bound gold nanoparticles within the lipid lamellae of the intercorneocyte fatty layer. OP penetrates the skin with exceptional efficiency, entering the bloodstream within 30 minutes. Its concentration peaked approximately two hours later.
Insulin-conjugated OP
Recombinant human insulin was then conjugated to OP (OP-I), with pegylated insulin serving as a control, having a similar molecular mass of 5 kDa. OP-I had the same secondary structure as insulin. It also showed unchanged receptor binding and association-dissociation constants, indicating that it retained the receptor specificity and affinity of native insulin intact.
OP-I skin permeability was measured by the drop in blood glucose following topical application. When compared with unbound insulin, the conjugated insulin produced the same decrease in blood glucose.
Thus, the study suggests that OP-I behaves similarly to insulin, binding to the insulin receptor with unchanged specificity and activating downstream pathways that result in glucose-lowering effects. OP-I had a longer half-life than insulin, probably because of its zwitterionic nature that resists plasma protein binding and removal from the blood. This extension was modest (15 to 20 minutes vs. 5 to 10 minutes for native insulin).
Modeling of the skin permeation of OP-I over time using confocal laser-scanning microscopy (CLSM) showed its uniform spread throughout the epidermis in half an hour. In contrast, native insulin and PEG-I remained on the skin surface. Thus, OP-I had the highest permeability coefficient among the three, approximately 4.5 and 9-fold that of the PEG-I and insulin, respectively.
OP effects on insulin and blood glucose
OP-I achieved comparable plasma levels to subcutaneous insulin within two hours. After this point, its levels were 60 % to 600 % higher than with insulin. The other two molecules did not affect blood insulin levels.
In mice with type 1 diabetes, OP-I normalized blood glucose levels. Once in the blood, OP-I was taken up mainly by the liver, lungs and kidneys, inducing insulin activity. Its activity was prolonged compared to subcutaneous native insulin, which was rapidly cleared from the bloodstream without significant accumulation in these tissues. OP-I regulated blood glucose levels better in diabetic mice than other treatments.
Similar findings were observed in minipigs, with OP-I entering the dermis and subcutaneous tissue at four hours following topical application. It induced normal blood glucose levels within two hours and maintained them for 12 hours.
Notably, topical OP-I application did not irritate the skin or induce inflammation. Repeated application in both mice and minipigs caused no structural changes to the stratum corneum or signs of immune activation.
Toward needle-free insulin
The skin-permeable polymer may enable non-invasive transdermal delivery of insulin, relieving patients with diabetes from subcutaneous injections and potentially facilitating patient-friendly use of other protein- and peptide-based therapeutics through transdermal delivery.
- Wei, Q., He, Z., Zhou, Z., et al. (2025). A skin-permeable polymer for non-invasive transdermal insulin delivery. Nature. doi: https://doi.org/10.1038/s41586-025-09729-x. https://www.nature.com/articles/s41586-025-09729-x
News
New Book! NanoMedical Brain/Cloud Interface – Explorations and Implications
New book from Frank Boehm, NanoappsMedical Inc Founder: This book explores the future hypothetical possibility that the cerebral cortex of the human brain might be seamlessly, safely, and securely connected with the Cloud via [...]
Miller School Researchers Pioneer Nanovanilloid-Based Brain Cooling for Traumatic Injury
A multidisciplinary team at the University of Miami Miller School of Medicine has developed a breakthrough nanodrug platform that may prove beneficial for rapid, targeted therapeutic hypothermia after traumatic brain injury (TBI). Their work, published in ACS [...]
COVID-19 still claims more than 100,000 US lives each year
Centers for Disease Control and Prevention researchers report national estimates of 43.6 million COVID-19-associated illnesses and 101,300 deaths in the US during October 2022 to September 2023, plus 33.0 million illnesses and 100,800 deaths [...]
Nanomedicine in 2026: Experts Predict the Year Ahead
Progress in nanomedicine is almost as fast as the science is small. Over the last year, we've seen an abundance of headlines covering medical R&D at the nanoscale: polymer-coated nanoparticles targeting ovarian cancer, Albumin recruiting nanoparticles for [...]
Lipid nanoparticles could unlock access for millions of autoimmune patients
Capstan Therapeutics scientists demonstrate that lipid nanoparticles can engineer CAR T cells within the body without laboratory cell manufacturing and ex vivo expansion. The method using targeted lipid nanoparticles (tLNPs) is designed to deliver [...]
The Brain’s Strange Way of Computing Could Explain Consciousness
Consciousness may emerge not from code, but from the way living brains physically compute. Discussions about consciousness often stall between two deeply rooted viewpoints. One is computational functionalism, which holds that cognition can be [...]
First breathing ‘lung-on-chip’ developed using genetically identical cells
Researchers at the Francis Crick Institute and AlveoliX have developed the first human lung-on-chip model using stem cells taken from only one person. These chips simulate breathing motions and lung disease in an individual, [...]
Cell Membranes May Act Like Tiny Power Generators
Living cells may generate electricity through the natural motion of their membranes. These fast electrical signals could play a role in how cells communicate and sense their surroundings. Scientists have proposed a new theoretical [...]
This Viral RNA Structure Could Lead to a Universal Antiviral Drug
Researchers identify a shared RNA-protein interaction that could lead to broad-spectrum antiviral treatments for enteroviruses. A new study from the University of Maryland, Baltimore County (UMBC), published in Nature Communications, explains how enteroviruses begin reproducing [...]
New study suggests a way to rejuvenate the immune system
Stimulating the liver to produce some of the signals of the thymus can reverse age-related declines in T-cell populations and enhance response to vaccination. As people age, their immune system function declines. T cell [...]
Nerve Damage Can Disrupt Immunity Across the Entire Body
A single nerve injury can quietly reshape the immune system across the entire body. Preclinical research from McGill University suggests that nerve injuries may lead to long-lasting changes in the immune system, and these [...]
Fake Science Is Growing Faster Than Legitimate Research, New Study Warns
New research reveals organized networks linking paper mills, intermediaries, and compromised academic journals Organized scientific fraud is becoming increasingly common, ranging from fabricated research to the buying and selling of authorship and citations, according [...]
Scientists Unlock a New Way to Hear the Brain’s Hidden Language
Scientists can finally hear the brain’s quietest messages—unlocking the hidden code behind how neurons think, decide, and remember. Scientists have created a new protein that can capture the incoming chemical signals received by brain [...]
Does being infected or vaccinated first influence COVID-19 immunity?
A new study analyzing the immune response to COVID-19 in a Catalan cohort of health workers sheds light on an important question: does it matter whether a person was first infected or first vaccinated? [...]
We May Never Know if AI Is Conscious, Says Cambridge Philosopher
As claims about conscious AI grow louder, a Cambridge philosopher argues that we lack the evidence to know whether machines can truly be conscious, let alone morally significant. A philosopher at the University of [...]
AI Helped Scientists Stop a Virus With One Tiny Change
Using AI, researchers identified one tiny molecular interaction that viruses need to infect cells. Disrupting it stopped the virus before infection could begin. Washington State University scientists have uncovered a method to interfere with a key [...]
